Anthem Biosciences Limited
Anthem Biosciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ANTHEM and BSE: 544449 (ISIN INE0CZ201020).
It has a market capitalisation of ₹45,415 crore, a last close of ₹808.50 on 2026-10-19, a one-year return of 6.7%.
Valuation: a price-to-earnings ratio of 78.85x, a price-to-book ratio of 14.93x, a dividend yield of 0.2%.
Profitability: return on equity of 19.5%, return on capital employed of 26.8%, an operating margin of 39.6%.
Balance sheet and ownership: debt-to-equity of 0.02x, promoter holding of 71.4%.
| Metric | Value |
|---|---|
| Market capitalisation | 45,415 |
| Last close | ₹808.50 |
| P/E (TTM) | 78.85x |
| P/B | 14.93x |
| Dividend yield | 0.2% |
| ROE (FY) | 19.5% |
| ROCE (FY) | 26.8% |
| Operating margin (TTM) | 39.6% |
| Debt / equity | 0.02x |
| Promoter holding | 71.4% |
| 1-year return | 6.7% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means